Clinical Therapeutics 2026 Full Archives TRUE PDF
About This Book
🔶 Clinical Therapeutics
🔻12 issues per year
🔻Full archive of 2026
🔻E-journal format: Full text PDF
subscription to this journal ((Recieved available issues in mega link and Rest issues will be sent there as soon as they are published))
The contents of this journal file are exactly the same as the contents of the printed journal of the original publication and are not a summary of this article, but rather in full text.
About the Journal
Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drugs, biologicals, and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research and development. In addition, Clinical Therapeutics features updates on specific topics collated by expert Topic Editors and Guest Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.
Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot study reports that assess drug safety and tolerability in all phases of development, new routes of drug administration and formulations, pharmacokinetics, pharmacodynamics, bioavailability, and biosimilarity and changes in practice guidelines, standards, policies and regulations are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of publicly accessible evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.
Beyond therapeutic clinical applications, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.
🔻12 issues per year
🔻Full archive of 2026
🔻E-journal format: Full text PDF
subscription to this journal ((Recieved available issues in mega link and Rest issues will be sent there as soon as they are published))
The contents of this journal file are exactly the same as the contents of the printed journal of the original publication and are not a summary of this article, but rather in full text.
About the Journal
Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drugs, biologicals, and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research and development. In addition, Clinical Therapeutics features updates on specific topics collated by expert Topic Editors and Guest Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.
Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot study reports that assess drug safety and tolerability in all phases of development, new routes of drug administration and formulations, pharmacokinetics, pharmacodynamics, bioavailability, and biosimilarity and changes in practice guidelines, standards, policies and regulations are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of publicly accessible evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.
Beyond therapeutic clinical applications, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.
